0% found this document useful (0 votes)
504 views

Reliance Capital - Initiating Coverage - Centrum 06122012

Reliance Capital's life insurance business is undergoing restructuring after regulatory changes in 2010. It has shifted its product mix away from short-term products and refocused on profitability over growth. This is improving productivity and profitability. The general insurance business is expected to turn profitable in FY14 due to regulatory changes improving tariffs and removing unprofitable business. The lending business is gaining traction with a focus on secured credit and niche customers, which will improve returns. Overall, improving business conditions and reducing debt will expand Reliance Capital's profitability profile.

Uploaded by

nit111
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
504 views

Reliance Capital - Initiating Coverage - Centrum 06122012

Reliance Capital's life insurance business is undergoing restructuring after regulatory changes in 2010. It has shifted its product mix away from short-term products and refocused on profitability over growth. This is improving productivity and profitability. The general insurance business is expected to turn profitable in FY14 due to regulatory changes improving tariffs and removing unprofitable business. The lending business is gaining traction with a focus on secured credit and niche customers, which will improve returns. Overall, improving business conditions and reducing debt will expand Reliance Capital's profitability profile.

Uploaded by

nit111
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 19

INDIA NBFC

Reliance Capital
Initiating Coverage 06 December 2012
Key Data
Bloomberg Code RCAPT IN RLCP.BO 245.6 245.6 111.3/2.1 476/223 3,559,125 10 Outperform Outperform

Buy
Target Price: Rs585 CMP: Rs436 Upside: 29%
*as on 06 December 2012

Phoenix rising again

Difficult business environment for equity linked Reuters Code businesses; sweeping regulatory changes in insurance (life & non-life) and a generally weak macro have led to Current Shares O/S (mn) significant erosion in return ratios of RCAP. However, Diluted Shares O/S(mn) the tide is gradually turning as individual business Mkt Cap (Rsbn/USDbn) segments overcome sector specific challenges and macro is on the mend leading to improved outlook for 52 Wk H / L (Rs) capital market linked businesses. Current market price Daily Vol. (3M NSE Avg.) disregards long term value seen by strategic investors Face Value (Rs) and under-appreciates a potent banking platform in 1 USD = Rs54.1 making. We initiate coverage with a Strong Buy Stock to Sector recommendation with an upside of ~30%.
Life insurance business: restructuring underway: RLIFE has undertaken restructuring of its business model after dramatic regulatory changes in 2010 with strong focus on profitability vs growth earlier. Shifted product mix, shedding of inactive agents, incremental focus on Tier I locations and potential bancassurance tie-up should drive productivity gains and hence improvement in profitability. Capital market business: better times ahead: A dominant market share (12%), gradually improving sentiments towards equity and better participation from retail investors brightens the medium term prospects of the asset management business. In addition, the 25 bps hike in expense ratio and leeway to recover service tax on expenses should allow asset management companies to increase commissions and in turn improve AUM inflows especially so for large funds such as RCAM. Gen. insurance business on brink of profitability: Dismantling of commercial third-party motor pool and anticipated firmness in insurance tariffs are expected to turn the fortunes of general insurance businesses. Effectively, the combined ratio (current industry average at ~120%) is expected to improve going forward. We expect RGEN to turn profitable in FY14 led by 1) absence of third party motor pool contribution in FY14 2) diversification of product mix and 3) gradual hike in tariff rates as PSU insurers aim profitability. Lending business gaining traction: Preference towards secured credit and niche focus on self-employed borrowers has endowed RCF with a healthy NIM and a strong hold on credit quality. We expect NIMs to improve going forward led by lower wholesale cost of funds (~50% of borrowings), which along with contained credit costs should drive expansion in return ratios even as loan book growth remains moderate (~15% YoY). Initiate coverage with Buy: Improving macro context and easing in business specific headwinds should drive expansion in return ratios for RCAP. In addition, unwinding of non-core investment to reduce debt should further improve profitability profile. At CMP, the stock is trading at a steep discount to its fair value of Rs585. We initiate coverage with a Buy rating.
Sector to Market

Shareholding Pattern
Others 19% DII 6%

Promoter 54%

FII 21%

As on 30 September 2012

One Year Indexed Stock Performance


160 150 140 130 120 110 100 90 80 70 Dec-11 Feb-12 Apr-12 Jun-12 Aug-12 Oct-12 Dec-12

RELIANCE CAPITAL

NSE S&P CNX NIFTY INDEX

Price Performance (%)


RCAPT NIFTY 1M 14.9 3.6 6M 45.7 18.7 1Yr 49.3 17.7

Source: Bloomberg, Centrum Research *as on 06 December2012

Bhavesh Kanani [email protected] +91 22 4215 9636

Sum of the parts valuation


Company/Business Life Insurance Asset Management Commercial Finance General Insurance Investments* Broking & Distribution Method Appraisal value % of AUM PB PB PB PE Value (Rs mn) 97,599 45,605 20,093 5,932 12,000 2,817 Multiple 5.3% 1.1 x 1.0 x 1.0 x 7.0 x Stake (%) 74 65 100 100 100 100 Share of RCAP (Rs mn) 72,223 29,735 22,102 5,932 12,000 2,817 Total Source: Company, Centrum Research Estimates; * Quoted investments only Per share 292 120 89 24 49 11 585 Contribution (%) 50 21 15 4 8 2

Please refer to important disclosures/disclaimers inside


Centrum Equity Research is available on Bloomberg, Thomson Reuters and FactSet

Shareholding pattern (%)


Sep-12 Promoter FII DII Others Total Source: BSE 54.1 21.0 5.7 19.2 100.0 Jun-12 54.1 20.0 5.7 20.1 100.0 Mar-12 54.1 20.9 5.4 19.6 100.0 Dec-11 54.1 19.9 5.0 20.9 100.0

Company Background
Reliance Capital Ltd is one of the largest financial services company in India in terms of net worth and offers multitude of services ranging from consumer finance to mutual funds, insurance (life & general) to asset reconstruction, stock broking to depository services. The company operates in all these sectors through the medium of subsidiaries namely Reliance Mutual Fund, Reliance Life Insurance, Reliance General Insurance, and Reliance Money. Recently the company made its foray into the upcoming consumer finance field.

Organization structure
Core Businesses Asset Management Broking & distribution
Retail & Institutional Broking Distribution of Third Party Products

Life Insurance

Commercial Finance

General Insurance

Mutual Fund

Exchanges

Offshore Funds

Finance and Investments Other Businesses

Private Equity

Pension Funds

Wealth Management

Managed Accounts

Investment Banking

Asset Reconstruction

Venture Capital

Key management personnel


Name Sam Ghosh Designation CEO, RCAP Profile Mr. Ghosh joined the company in April 2008. Prior to that he was the regional CEO of Middle East and India Sub Continent region of Allianz after playing key role in various capacities and geographies for Allianzs global operations. By qualification, he is a Chartered Accountant from England. Mr. Bapna. a chartererd accountant by qualification, has been with the company since 2004 and with the Group since 1999. His earlier experience includes stint as CFO of Reliance Capital Asset Management Ltd and Reliance Consumer Finance. He has over eleven years of experience in varied business environmentsmanufacturing and financial services. After spending more than 7 years with Reliance Capital Asset Management Ltd. as Head of Fixed Income, he is now responsible for driving various debt related initiatives of Reliance Capital Limited and its subsidiaries. Prior to joining the group, he was Vice President (fixed income) at Alliance Capital Asset Management Ltd. By qualification, he is a management graduate from IIMA. He has been leading the commercial finance business since December 2007. Before joining Reliance Capital, he was the Financial Controller and Company Secretary of Citicorp Finance. He has been with RCAM since October 2003 and in that time he has been instrumental in expanding RCAMs footprints in both domestic and international territories. Overall, he has more than fifteen years of leadership experience with NBFCs and Banks Prior to joining RCAP, he held the position of Director, Corporate Centre & CFO in ICICI Lombard. He has total work experience of over 17 years in leadership positions in corporate management functions. With over 27 years experience in the life insurance industry, Malay brings to the table, distribution acumen as well as rich exposure and knowledge of Life Insurance operations. He joined Reliance Capital in April 2008 as Deputy CEO of Reliance Life Insurance.

Amit Bapna

CFO, RCAP

Amitabh Mohanty

Head, Debt Strategies

K. V. Srinivasan

CEO, Reliance Commercial Finance CEO, Reliance Capital Asset Management CEO, Reliance General Insurance ED & President, Reliance Life Insurance Company

Sundeep Sikka

Rakesh Jain

Malay Ghosh

Vikrant Gugnani

He leads international business strategy across all lines of Reliance Capital businesses. A Chartered CEO, International Businesses Accountant by qualification, he has over 19 years of extensive experience in the financial industry and has worked in various countries with global firms like Citibank and S. B. Billimoria & Co CIO, RCAP He was heading the Equity Investments at Reliance MF for nearly 10 years. In his 20 years of experience, he has served at UBS, Peregrine Securities & Motilal Oswal Securities.

Madhusudan Kela

Source: Company, Centrum Research

Reliance RelianceCapital Capital

Life insurance business: shifting gears


Sweeping regulatory changes by IRDA in 2010 had a dramatic effect on life insurance business growth momentum with APE de-growing materially for private players vs the heady growth prior to the reforms. On a positive note, the regulatory changes have forced industry players to shift focus from relentless growth in new business premiums to customer centricity and profitability. While the transition phase has been painful, it has helped remove inefficiencies associated with growth oriented business models: 1) short term products with limited profiling of customer needs and hence weak profitability 2) incentive structure of front-line employees skewed towards new business premiums and 3) weak persistency rates. However, a fair part of the transition is behind us, in our view, as reflected by a decline in opex and commission ratios and rebalancing of product mix in favor of traditional products. Exhibit 1: Trend in APE (individual) growth
40% 30% 20% 10% 0% -10% -20% -30% FY2009 FY2010 Private FY2011 LIC FY2012 Industry Oct-12

Exhibit 2: Trend in market share: LIC vs private players


80% 70% 60% 50% 40% 30% 20% 10% 0% FY05 FY06 FY07 FY08 FY09 FY10 LIC FY11 FY12

Private Insurers

Source: Company, Centrum Research

Source: Company, Centrum Research

Exhibit 3: Trend in market share: private players


14% 12% 10% 8% 6% 4% 2% 0% FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12

Bajaj Allianz Kotak Life


Source: IRDA, Centrum Research

Birla Sun Life Max Life

HDFC Life Reliance Life

ICICI Pru SBI Life

Exhibit 4: Trend in commission ratio


20% 15% 10% 5% 0% FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12 Q1FY13 HDFC Life Max Life Bajaj Allianz ICICI Pru Reliance Life Birla Sun Life Kotak Life SBI Life

Exhibit 5: Commission ratio: peer comparison


9% 8% 7% 6% 5% 4% 3% 2% 1% 0% Kotak Life Bajaj SBI Life Allianz HDFC Birla Sun ICICI Pru Reliance Max Life Life Life Life

Source: Company, Centrum Research

Source: Company, Centrum Research

Reliance RelianceCapital Capital

Exhibit 6: Trend in branches


2,500 2,000 1,500 1,000 500

Exhibit 7: Branch network: peer comparison


1,400 1,200 1,000 800 600 400

0 FY05 FY06 FY07 Bajaj Allianz ICICI Pru Reliance Life Br FY08 FY09 FY10 Birla Sun Life Kotak Life SBI Life FY11 FY12 HDFC Life Max Life

200 0 FY05 FY06 FY07 FY08 FY09 FY10 FY11 FY12

Source: Company, Centrum Research

Source: Company, Centrum Research

Exhibit 8: Trend in expense ratio


100% 80% 60% 40% 20% 0% FY05 FY06 FY07 Bajaj Allianz ICICI Pru Reliance Life FY08 FY09 FY10 Birla Sun Life Kotak Life SBI Life FY11 FY12 Q1FY13 HDFC Life Max Life

Exhibit 9: Expense ratio: peer comparison


45% 40% 35% 30% 25% 20% 15% 10% 5% 0% SBI Life HDFC ICICI Pru Bajaj Max Life Birla Sun Kotak Reliance Life Allianz Life Life Life

Source: Company, Centrum Research

Source: Company, Centrum Research

Exhibit 10: 1 year persistency: peer comparison


90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Bajaj Reliance Kotak ICICI Pru HDFC Allianz Life Life Life SBI Life Max Life Birla Sun Life

Exhibit 11: 5 year persistency: peer comparison


80% 70% 60% 50% 40% 30% 20% 10% 0% HDFC Life Kotak Life SBI Life Max Life Bajaj Birla Sun ICICI Pru Reliance Allianz Life Life

Source: Company, Centrum Research

Source: Company, Centrum Research

Life insurance industry at inflection point: With a large part of regulatory overhang behind us, the life insurance industry has stabilized its operations and has adjusted its business model to the new operating environment. Given that, we believe the industry is at an infection point, structural positives (rising incomes, higher share of working population and increasingly sophisticated customer needs) should drive the next leg of growth. Increase in foreign direct investment (FDI) limit will only act as a catalyst to this second phase of the decisively promising journey ahead. Life insurance business: restructuring underway: In line with the industry, RLIFE has undertaken restructuring of its business model after dramatic regulatory changes in 2010 with strong focus on profitability vs growth earlier. Product mix has shifted away from ULIPs to traditional products. Though this has lowered profitability in near term it should augur well in medium to long term in the form of better persistency. Shedding of inactive agents, consolidation of branch network and incremental focus on Tier I and 2 locations (vs current focus on Tier 3 centres) to tap the big-ticket market should lead to productivity gains. Moreover, RLIFE is exploring bancassurance possibilities aggressively given the lucrative cost-benefit equation offered as well as the proposed changes to regulations governing bancassurance channel.

Reliance RelianceCapital Capital

Product mix transition largely over: Given the regulatory changes, the life insurance industry has changed its product mix gradually in favor of traditional products. In line, RLIFE too has shifted away from ULIPs (forming 90% of premium at one point to 20% now). Focus on productivity: In addition to the change in product mix, RLIFE has adopted a multipronged approach to improve productivity and efficiency. For instance, the agency force continues to be trimmed as inactive agents are dropped. Also, RLIFE has not added new branches since FY2010 with a view to optimally utilize the existing infrastructure. A review of RLIFEs operating expense ratio indicates that there still exists significant scope for operating leverage. Exhibit 12: Reliance Life Insurance: agency force
250,000 200,000 150,000 100,000 50,000 0 Q1FY10 Q2FY10 Q3FY10 Q4FY10 Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13
FY12

Source: Company, Centrum Research

Exhibit 13: Reliance Life Insurance: branches


1,400 1,200 1,000 800 600 400 200 0 FY05
Source: Company, Centrum Research

FY06

FY07

FY08

FY09

FY10

FY11

Incremental expansion in Tier I locations: So far, RLIFEs 1230 strong branch network is in Tier 2 and 3 centres focusing on the middle class. With fairly strong presence in Tier 2 & 3 centres, RLIFE now intends to expand in Tier 1 centres (Top 15 cities) given the strong demand for term insurance and big-ticket nature of opportunity. Expansion in Tier 1 centres should augur well for overall productivity of the operations. Bancassurance channel - a distinct possibility: One of the key differences between RLIFE and close rivals is RLIFEs strong dependency on agency channel due to the absence of bancassurance. Bancassurance has its obvious benefits such as: ready access to banks customer base, access to customers financial information, cost efficiency as there is no investment in physical infrastructure, repeat business due to customer loyalty. The absence of bancassurance channel has translated into lower persistency rates and higher commission and operating expense ratios for RLIFE. While most leading banks have promoted their own insurance companies (and hence no scope of tie-up), the remaining banks demand uneconomical terms (upfront payment + normal commission) rendering bancassurance channel unviable. However, IRDA has proposed new regulations governing bancassurance which is likely to open up bancassurance channel options for RLIFE. While such a development could be a little time away, addition of bancassurance to channel portfolio would be immensely beneficial for RLIFE from a profitability and productivity perspective.

Reliance RelianceCapital Capital

Q2FY13

Asset management business: dominant position, improving outlook


With over Rs1.5tn of assets under management (MF + others), RCAM holds a dominant position in domestic asset management business with 12% market share in mutual fund industry. RCAM has been focusing on promoting systematic investment plans (SIPs) and caters to a wide customer base of over 6.5 million. The dominant position and gradually improving outlook for equity asset class augur well for the asset management industry in general and RCAM in specific. The bright outlook for Indias asset management market is well brought out by the uptick in valuations of M&A deals in the industry. Exhibit 14: M&A activity in asset management industry
Year 2002 2003 2004 2005 2005 2007 2007 2007 2008 2009 2009 2010 2011 2012 Acquirer Franklin Templeton MF Standard Life Societe General BNP Paribas SBI, PNB, BOB, LIC UBS Robeco Group NV Eton Park IDFC SSKI Nomura T Rowe Price Natixis Benchmark AMC Invesco Target Pioneer ITI HDFC AMC SBI MF Sundaram AMC UTI Mutual Standard Chartered MF Canbank MF Reliance AMC Standard Chartered MF LIC Mutual Fund UTI AMC IDFC MF Goldman Sachs AMC Religare AMC Valuation (% of AUM) 6.00 5.20 7.70 7.10 5.00 5.00 10.50 ~10 6.40 2.50 3.60 5.50 4.43 6.40

Source: Media reports, Centrum Research

Positive equity outlook + dominant position: Domestically, equity asset class has performed well on CYTD basis with Sensex up ~27% as sentiment turned positive post announcement of reforms and drove in healthy FII inflows. Incremental reform announcements and anticipated revival in economic activity should keep the equity asset class in good stead. In turn, this should lead to improvement in participation from retail investors who have avoided equity asset class in recent years. RCAM with its dominant market share and wide distribution network would be a key beneficiary and hence we expect the declining trend in MF AUM to reverse in FY2013.

Exhibit 15: Trend in MF AUM


(Rs bn) 1,200 1,000 800 600 400 200 0 FY2010 FY2011 FY2012 FY2013E % YoY FY2014E Total MF AUM
Source: Company, Centrum Research

Exhibit 16: Trend in MF AUM mix


100% 40% 30% 20% 10% 0% -10% -20% -30% 40% 20% 0% FY2008 FY2009 FY2010 FY2011 FY2012 FY2013E FY2014E Equity
Source: Company, Centrum Research

80% 60%

Debt

Reliance RelianceCapital Capital

Exhibit 17: Trend in market share


8,000 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 FY2008 FY2009 FY2010 FY2011 FY2012 18% 17% 16% 15% 14% 13% 12% 11% 10% 9% 8%

Industry AUM (Rsbn)


Source: Company, Centrum Research

Market Share - RCAM

AUM Slab <1 bn 1 bn - 3 bn 3 bn - 7 bn > 7 bn

Expense Ratio Earlier Revised 2.50 2.25 2.00 1.75 3.03 2.76 2.48 2.21

Hike in expense ratio to improve profitability: Since the removal of entry load on mutual fund units, inflows into AUM pool have dropped sharply with aggressive distribution of mutual funds loosing steam. However, a hike of 25bps in expense ratio is being considered by the regulator with a view to revive the inflows into mutual funds. Currently, the expense ratio is capped due to the slab structure (refer to exhibit below). In addition, there is a proposal to recover service tax on the expense ratio from unit buyers, which currently is borne by mutual fund companies. A hike in expense ratio would allow asset management companies to offer higher commission to distributors which in turn would attract inflows. Importantly, since the expense ratio is the function of the total corpus, the benefit of the increase in expense ratio will be more for bigger fund houses than smaller ones. RCAM being a dominant player in asset management industry stands to gain substantially if the proposal gets accepted and implemented. Nippon allocation could be game changer: RCAP had sold a 26% stake in Reliance Mutual Fund to Nippon Life Insurance for Rs 14.5bn during 2012 in addition to 26% stake sale in life insurance business. Nippon Life Insurance, Japan's biggest life insurer, manages an AUM of over $600 billion in assets (highest in the world for any life insurer). RCAM should benefit from Nippon Lifes allocation to Indias equity opportunities. Refer to the exhibit below for a break-up of Nippon Lifes AUM. As evident, the foreign securities portfolio stands at ~$140bn of which even 1% equity allocation to India would mean ~Rs80bn (10% of RCAMs MF AUM). Exhibit 18: Nippon life insurances AUM breakup
Domestic stocks, 73.9 Loans, 106.1

Othe asset classes, 52.3

Foreign securities, 141.2

Corporate bonds, 39.2 Local govt bonds, 19.3 Other securities, 4.5 National govt bonds, 178.5

Source: Company, Centrum Research

Reliance RelianceCapital Capital

General insurance business: profitability in sight


The general insurance industry, just like life insurance, has been going through tough times. At the heart of the widening losses of general insurance industry are two key factors 1) Motor third party pool mechanism and 2) pricing bloodbath since de-tariffing. Given that motor third party pool has been dismantled and pricing sanity is gradually returning, we see the fortunes of general insurance industry turning positive over the medium term. Motor third party pool dismantled: IRDA dismantled the third party motor insurance pool (initiated in 2007) given persistent losses for private insurers due to alleged mis-management of the pool handled by the General Insurance Corporation. Under the current set up, insurers are free to underwrite risks independently. This implies that pricing will gradually become riskbased and would be a function of claims, age, and frequency of accidents etc. Pricing sanity returning gradually: The de-tariffing of general insurance premiums in 2007 had led to a bloodbath with cut-throat competition pushing down premiums sharply (as much as +50% on certain products). Lately, there has been an upward bias given the finance ministrys instructions to PSU general insurance players to improve profitability and efficiency. Currently, the combined ratio for PSU general insurers is hovering around 120% with combined losses of 4 PSU general insurers at around Rs65bn for FY2012 and cumulative loss of Rs150bn since detariffication. Given the dominant share of PSU players in general insurance, upward revision in pricing will allow private players to price their products profitably.

Reliance general insurance: Turnaround ahead


Given the improvement in operating environment (dismantling of motor third party pool) and anticipated return of sanity in pricing of general insurance product, we expect RGEN to turn around in FY2014. The turn in fortunes would be driven by 1) lower contribution to motor pool losses (only ~Rs700mn remaining to be booked in FY14) 2) anticipated improvement in pricing to improve margins and 3) sustained healthy growth in gross written premiums. Exhibit 19: Trend in revenue & bottomline
Particulars (Rs mn) Gross written premium Premium Earned (Net) Profit / (Loss) Before Tax Net Profit /(Loss) After Tax FY2010 19,797 13,992 (905) (504) FY2011 16,554 12,938 (3,098) (3,116) FY2012 17,125 11,631 (3,415) (3,432) FY2013E 17,982 12,048 (522) (552) FY2014E 19,240 12,891 204 173 FY2015E 21,165 14,180 1,025 871

Source: Company, Centrum Research Estimates

Declining contribution to motor pool losses: Since the dismantling of the Motor third party loss pool, the contribution of RGEN to the pool has been on the decline. For FY2012, RGEN contributed Rs2.2bn to the motor third party loss pool while in FY2013 the share of Rs1.8bn has been up-fronted in Q2FY13 itself. This leaves incremental loss share of just Rs600-700mn to be booked in FY2014. The dramatic reduction in the contribution should boost RGENs profitability. Exhibit 20: Trend in RGENs share in motor pool losses (Rs mn)
FY2008 0.0 (500.0) (1000.0) (1500.0) (2000.0) (2500.0)
Source: Company, Centrum Research Estimates

FY2009

FY2010

FY2011

FY2012

FY2013E FY2014E

(310)

(370)

(360) (650)

(1,840) (2,160)

(1,840)

Reliance RelianceCapital Capital

Focus on diversification: While the premium mix remains heavily skewed towards motor third party, RGEN has been consciously trying to diversify its premium flow mix. As evident in the table below, the share of Motor segment for RGEN stands at 55% compared with 48% for private players and 41% for the industry. As against this, RGEN lags the industry and other private players in the health insurance segment. With a view to balance its premium mix, RGEN is focusing on fire and engineering product segments given its big ticket and relatively less risky business profile. Exhibit 21: RGEN - Premium %YoY (June2012) Exhibit 22: Industry - Premium %YoY (June2012)
(%) 200.0 150.0 100.0 50.0 0.0 (50.0) All Others Motor OD Per Accident Motor Liability Engineering Aviation Health Motor TP Marine Cargo Marine Marine Hull Grand Total Fire

(%) 50.0 40.0 30.0 20.0 10.0 0.0 (10.0) (20.0) All Others Engineering Motor OD Liability Personal Accident Aviation Health Marine Hull Grand Total Motor TP Marine Marine Cargo Motor Fire

Source: Company, Centrum Research

Source: Company, Centrum Research

Exhibit 23: Premium mix (June2012) - RGEN vs industry


Product Segment (%) Personal Accident Marine Cargo Marine Misc Liability Engineering Fire Health Motor TP Motor OD Reliance 2 2 2 3 4 6 13 14 24 31 Private 3 4 4 3 3 3 14 20 17 31 Public 2 3 7 10 2 4 14 26 18 17 Industry 2 4 6 7 2 4 14 23 18 23

Higher than industry Lower than industry

Source: Company, Centrum Research

Operational restructuring to aid profitability: In addition to the improving dynamics for the general insurance industry, RGEN has undertaken operational restructuring to improve productivity and efficiency. For instance, RGEN has minimized the use of written cover notes for motor insurance and shifted the activity to a centralized system with a view to contain frauds and ensure a tight leash on claims etc. As evident below, the claims in motor (own damage) were unusually high at 88% by the end of 1 year (vs 50% for third party) pointing to potential fraud or malpractices in operations. Increased productivity of operations and streamlining of processes should aid improvement in profitability. Exhibit 24: Product wise trend in claims (cumulative basis)
100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 0 day Fire Engineering
Source: Company, Centrum Research

30 d Marine Health

31 d to 6 m Motor OD Miscellaneous

6 m to 1 yr Motor TP

Reliance RelianceCapital Capital

Lending business to gain traction


The commercial finance business has been focusing on growing only secured assets loan against property (LAP), mortgages, commercial vehicles (CVs) and business loans (SME). As evident in the exhibit below, the mortgages (LAP+Mortgages) constitute ~50% of the loan book. RCAP has adopted a calibrated approach in the lending business since FY2012 (refer to chart below) with loan growth across segments moderating. During H1FY13, while the loan book remained largely flat, mortgages (LAP+home loans) and auto segments grew at a healthy pace at the cost of CV and SME segments. RCAP intends to grow the commercial lending book at ~15% YoY for FY13 and FY14. Exhibit 25: Trend in RCFs loan mix
100% 80% 60% 40% 20% 0% Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13 Q2FY13
-50% -100%
Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13 Q2FY13

Exhibit 26: Trend in segmental loan growth


150% 100% 50% 0%

Home Loan

LAP

CVs

Auto

Infra financing

SME

Others

Loan growth
Source: Company, Centrum Research

Mortgages

CVs

Auto

SME

Source: Company, Centrum Research

Niche positioning = healthy pricing power: The commercial lending business is focused on self-employed customers, a segment better served by NBFCs rather than banks. Dissecting further, RCAP typically serves relatively low risk and high ticket customers in the self employed segment as reflected by the loan yields (~15% vs 18-20% for many NBFCs). The niche positioning has endowed RCAP with a healthy pricing power given the low interest rate sensitivity of self-employed customers. Exhibit 27: Segmental yield comparison (%)
16 14 12 10 8 6 4 2 0 Home Loan LAP Infrafinancing Auto SME CVs 13 14 13 14 15 15

Source Company, Centrum Research

Declining wholesale funding costs to boost NIMs: Due to the skewed borrowing profile towards wholesale-funded coupled with tight liquidity in recent quarters, NIMs for lending businesses have seen material contraction. The NIM has contracted from ~6% in Q1FY11 to 4% in Q1FY13. However, the benefit of easing in wholesale funding costs is beginning to flow in with Q2FY13 NIMs witnessing a 10bps uptick as cost of funds have eased gradually. We expect NIMs to improve further in FY13 and FY14 led by further easing in wholesale funding costs.

10

Reliance RelianceCapital Capital

Exhibit 28: Trend in Yields, cost of funds and NIM


15% 14% 13% 12% 11% 10% 9% 8% Q1FY11 Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13 Q2FY13
Oct-12

6.00% 5.50% 5.00% 4.50% 4.00% 3.50%

Yield
Source Company, Centrum Research

Cost of Funds

NIM RHS

Exhibit 29: Trend in wholesale funding costs


12.0 11.5 11.0 10.5 10.0 9.5 9.0 8.5 8.0

Dec-11

Mar-12

Jun-11

Oct-11

Apr-11

Nov-11

Apr-12

Jun-12

Aug-11

May-11

May-12

Aug-12

3m
Source Company, Centrum Research

6m

12m

Strong hold on asset quality: RCAPs niche positioning (relatively low risk self employed profile of customers) along with robust underwriting processes have ensured a strong asset quality matrix. As evident in the exhibit below, %GNPA stand at a healthy 1.5% (90 day basis) at the end of Q2FY13 while the provisioning coverage has been shored up to 70% in recent quarters. The healthy asset quality matrix (relatively better than many leading banks), despite limited access to supplementary data on borrowers available to banks, speaks volumes about the robust underwriting standards and processes put in place. Given the calibrated approach towards lending since FY2012 and clear focus on secured products, we expect asset quality to remain healthy.

11

Reliance RelianceCapital Capital

Nov-12

Jul-11

Sep-11

Feb-12

Jul-12

Sep-12

Jan-12

Exhibit 30: Trend in %GNPA & coverage ratio


2.50% 2.00% 1.50% 1.00% 0.50% 0.00% Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13 Q2FY13 60% 50% 40% 30% 20% 10% 0% Q2FY11 Q3FY11 Q4FY11 Q1FY12 Q2FY12 Q3FY12 Q4FY12 Q1FY13 Q2FY13 90% 80% 70% 60% 50% 40% 30% 20% 10% 0%

%GNPA
Source Company, Centrum Research

Coverage ratio

Better macro should unleash growth potential: After robust loan book expansion during FY2011 and H1FY12, RCAP has dramatically lowered its loan book expansion with % YoY growth in lower single digits for the past three quarters. The shift in growth pattern is driven by the focus on maintaining robust asset quality matrix and the endeavor to build a profitable book. In line, we believe that gradually improving macro scenario and positive sentiments should pave the way for improvement in the growth momentum for lending business. The management has already guided for a higher growth rate (~15% YoY) for FY13 and FY14. Importantly, the unlocking of capital from investment portfolio and anticipated dividend flow from subsidiaries over medium term should ensure sufficient capital flow for expansion of the loan book. Exhibit 31: Trend in loan book, % YoY
160,000 140,000 120,000 100,000 80,000 60,000 40,000 20,000 0

Loan Book (Rsmn)


Source Company, Centrum Research

Loan growth

12

Reliance RelianceCapital Capital

Investments cleanup, dividend to lower leverage


Besides the core businesses, RCAP holds a mammoth investment portfolio of ~Rs130bn on cost basis (including investment in subsidiaries). Dissecting further, ~50% of the investment portfolio is for subsidiaries and associates while the remaining portion represents other investments (quoted & unquoted). The quoted equity portfolio (after provisions & booking losses in Q2FY13) currently stands at ~Rs12bn, which is close to the market value of the portfolio. Given the huge portfolio, RCAP has appointed officials to focus on liquidating the investment pool over next 24 months with a view to unlock capital. The proceeds from the liquidation of investment portfolio as well as dividends flow from various subsidiaries should help RCAP lower its leverage materially. Exhibit 32: Trend in Debt : Equity ratio for RCAP (standalone)
3.0 2.5 2.0 2.0 1.5 1.5 1.0 0.5 0.0 FY2003 FY2004 FY2005 FY2006 FY2007 FY2008 FY2009 FY2010 FY2011 FY2012 0.3 0.4 0.1 0.1 0.3 1.7 1.7 2.7

Source Company, Centrum Research

Exhibit 33: Trend in investment portfolio


(Rs bn) 140 120 100 80 60 40 20 0 FY2005 FY2006 FY2007 FY2008 FY2009 FY2010 FY2011 FY2012 Quoted Investments at cost
Source: Company, Centrum Research

Exhibit 34: Trend in segmental loan growth


(Rs bn) 50 40 30 20 10 0 FY2005 FY2006 FY2007 FY2008 FY2009 FY2010 FY2011 FY2012 Quoted Investments at cost
Source: Company, Centrum Research

Unquoted Investments at cost

Quoted Investments at mkt. val.

All geared up for banking license


RCAP has declared its intention to apply for a banking license to RBI. While RBI has openly expressed its discomfort over giving banking licenses to the corporate sector, we believe that suitable amendments to the Banking Regulation Act should allay RBIs concerns. Importantly, the new banking licensees are being considered with a view to improve penetration of financial services in areas not covered by banks currently. Given this objective, the potential new banking players would have to commit substantial capital in building the infrastructure with a willingness to navigate the long gestation period in the light of lower profitability potential in rural and semi-urban locations. In this context, involvement of corporate houses becomes inevitable as they have deep pockets and the management bandwidth required for successful foray into banking while meeting RBIs objectives.

13

Reliance RelianceCapital Capital

Valuation discount unjustified


Over last 12 months, Reliance Capital has sold 26% stake each in Reliance Capital Asset Management and Reliance Life for Rs56bn and Rs117bn respectively. The deals imply a combined value of ~Rs175bn for the life insurance and asset management businesses significantly above the current market cap of ~Rs100bn even if we were to ignore the value in other businesses: general insurance, consumer finance, broking & distribution and investments. The disconnect between the current market price of Reliance Capital and the implied valuation from these deals could be because: (i) investors believe that what Nippon has paid for these businesses is much higher than their fair valuation and (ii) other issues surrounding Reliance ADAG group. However, given the steep discount the risk reward appears favourable at these valuations.

Conservative valuation approach...


Our valuation assumptions are significantly conservative compared with the valuation implied by stake sale transactions over the past one year. The below tables show that for life insurance and asset management businesses, our valuation estimates are ~40% lower than the deal implied valuations. Hence we have taken a balanced approach and assigned 50% weight to our estimates and 50% weight to deal implied valuations. Exhibit 35: Conservative estimates
Business Life Insurance Asset Management Total Source Company, Centrum Research Estimates Deal Based Value 117,769 55,769 173,538 Centrum Estimate 77,428 35,441 112,869 Variance (%) (34) (36) (35) Weighted Valuation 97,599 45,605 143,204

Exhibit 36: Valuation - Reliance Life Insurance


Particulars (Rs mn) Opening balance of VIF APE APE growth (%) NBAP margin (%) Value of New Business (Calc) In-force unwinding Estimated VIF NAV Embedded Value Structural Value Appraisal value Source Company, Centrum Research Estimates FY2011 18,819 23,597 (36) 16.7 3,941 21,642 25,242 2,930 28,172 18,408 46,580 FY2012 25,242 14,737 (38) 15.6 2,299 29,029 30,829 9,059 39,887 18,870 58,758 FY2013E 30,829 14,737 0 16.0 2,358 35,453 37,811 10,401 48,212 19,343 67,555 FY2014E 37,811 15,768 7 15.0 2,365 43,482 45,848 11,701 57,549 19,879 77,428 FY2015E 45,848 17,345 10 14.0 2,428 52,725 55,153 13,001 68,154 20,432 88,587

Exhibit 37: Reliance Life Insurance


Weighted Value (Rs mn) Deal based Appraisal Value Method Weighted Value Economic Interest (%) Shares Outstanding Contribution per share Source Company, Centrum Research Estimates Weight (%) 50 50 Value 117,769 77,428 Weighted Value 58,885 38,714 97,599 74 247 292

Exhibit 38: Reliance Capital Asset Management


Weighted Value (Rs mn) Deal based % of AUM Method Weighted Value Economic Interest Shares Outstanding Contribution per share Source Company, Centrum Research Estimates Weight (%) 50 50 Value 55,769 35,441 Weighted Value 27,885 17,721 45,605 65 247 120

14

Reliance RelianceCapital Capital

Exhibit 39: Commercial finance & Broking/Distribution business


Commercial Finance (Rs mn) Assets (loan book) % YoY RoA (PBT) (%) PAT Networth GNPA Adjusted NW Broking & Distribution (Rs mn) Broking & Distribution PBTl PAT @ 34% tax PBT growth (%) Source Company, Centrum Research Estimates FY12 125,383 2 0.92 21,064 2,200 18,864 FY12 553 365 FY13E 144,190 15 1.00 1,348 22,008 2,700 19,308 FY13E 581 383 5 FY14E 165,819 15 1.00 1,550 23,093 3,000 20,093 FY14E 610 402 5 FY15E 190,692 15 1.00 1,783 24,341 3,000 21,341 FY15E 640 423 5

...~30% upside still


Despite very conservative valuation approach, the current market price implies a significant 30% upside to our fair value estimate of Rs585. Exhibit 40: Sum of the parts valuation
Company/Business Life Insurance Asset Management Commercial Finance General Insurance Investments* Broking & Distribution Method Appraisal value % of AUM PB PB PB PE Value (Rs mn) 97,599 45,605 20,093 5,932 12,000 2,817 Multiple 5.3% 1.1 x 1.0 x 1.0 x 7.0 x Stake (%) 74 65 100 100 100 100 Share of RCAP (Rs mn) 72,223 29,735 22,102 5,932 12,000 2,817 Total Source Company, Centrum Research Estimates; * Quoted investments only Per share 292 120 89 24 49 11 585 Contribution (%) 50 21 15 4 8 2

Risks to our call


Weakness in capital markets: All the businesses of RCAP including (life insurance) are inherently linked to the state of capital markets (directly or indirectly). Hence weakness in capital markets can impact business performance and alter the earnings trajectory we have envisaged. Change in regulatory regime: As seen in past, RCAPs insurance and asset management businesses are exposed to regulatory changes. Any major regulatory changes by SEBI and IRDA can impact the asset management and insurance businesses meaningfully. Intense competition: Reliance Capital faces intense competition in almost all the businesses life insurance, asset management, general insurance and broking. Inability to cope with the competition by offering better products at competitive prices could impact growth. Undercutting by new entrants could also impact profitability and our assumptions.

15

Reliance RelianceCapital Capital

Financials (Consolidated)
Exhibit 41: Income Statement
Y/E March (Rsmn) Interest income Interest expense Net interest income Non interest income Total income Operating expenses Pre-provision op (PPOP) Investments written off Provision for NPA Provision for std debts Total provisions Profit Before Tax (PBT) Tax Net Profit (Pre minority) Minority & Associates Reported Net Profit FY11 22,320 14,640 7,680 33,040 40,720 35,590 5,130 (110) 2,200 140 2,230 2,900 570 2,330 580 2,910 FY12 28,220 22,500 5,720 38,050 43,770 36,060 7,710 1,300 1,130 90 2,520 5,190 1,900 3,290 1,290 4,580 FY13E 29,913 22,725 7,188 43,758 50,946 39,738 11,208 1,300 1,243 95 2,638 8,570 2,914 5,656 (70) 5,726 FY14E 32,306 23,180 9,127 50,320 59,447 45,774 13,673 1,300 1,367 100 2,767 10,906 3,708 7,198 (70) 7,268 FY15E 35,537 24,338 11,198 57,869 69,067 52,491 16,576 1,300 1,504 105 2,909 13,667 4,647 9,020 (70) 9,090

Exhibit 43: Segmental details


Y/E March (Rsmn) Revenue Finance & Investments Asset Management Commercial Finance Broking & Distribution General Insurance Others Total Revenue mix (%) Finance & Investments Asset Management Commercial Finance Broking & Distribution General Insurance Others PBT Finance & Investments Asset Management Commercial Finance Broking & Distribution General Insurance Others Total PBT mix (%) Finance & Investments Asset Management Commercial Finance Broking & Distribution General Insurance Others FY08 17,077 4,728 3,946 0 23,440 0 49,191 FY09 18,752 3,907 12,052 563 23,114 2,386 60,776 FY10 11,813 6,460 13,252 2,585 23,862 6,211 64,184 FY11 10,886 6,619 13,741 3,109 21,809 3,178 59,342 FY12 17,090 5,640 19,450 4,661 21,920 3,490 72,251

35 10 8 0 48 0

31 6 20 1 38 4

18 10 21 4 37 10

18 11 23 5 37 5

24 8 27 6 30 5

Source: Company, Centrum Research Estimates

Exhibit 42: Balance Sheet


Y/E March (Rsmn) Share Capital Reserves and Surplus Total shareholders' funds Minority interest Total Borrowings Other current liabilities Other liabilities Total Liabilities Total fixed assets Total investments Total loans Deferred tax assets (Net) Other non current assets Other current assets Total Assets FY08 2,460 75,440 77,900 1,630 203,740 37,170 430 320,870 2,140 123,010 157,420 700 13,160 24,440 320,870 FY09 2,460 115,220 117,680 1,310 195,900 38,120 420 353,430 2,810 147,590 168,670 450 11,410 22,500 353,430 FY10 2,460 118,083 120,543 1,310 199,763 41,170 441 363,227 3,091 152,018 183,850 450 11410 12,408 363,227 FY11 2,460 121,717 124,177 1,310 213,342 45,287 463 384,579 3,400 156,578 202,235 450 11410 10,505 384,579 FY12 2,460 126,262 128,722 1,310 224,799 49,815 486 405,133 3,740 161,276 224,481 450 11410 3,776 405,133

11,913 1,931 361 0 (1,628) 0 12,577

10,375 1,147 922 140 502 115 13,201

3,426 2,303 1,350 149 (906) (274) 6,048

1,204 2,241 2,693 332 (3,098) (68) 3,305

3,700 2,100 2,540 554 (3,420) 280 5,754

95 15 3 0 (13) 0

79 9 7 1 4 1

57 38 22 2 (15) (5)

36 68 81 10 (94) (2)

64 36 44 10 (59) 5

Source: Company, Centrum Research Estimates

Source: Company, Centrum Research Estimates

16

RelianceCapital Capital Reliance

Appendix A
Disclaimer
Centrum Broking Limited (Centrum) is a full-service, Stock Broking Company and a member of The Stock Exchange, Mumbai (BSE) and National Stock Exchange of India Ltd. (NSE). Our holding company, Centrum Capital Ltd, is an investment banker and an underwriter of securities. As a group Centrum has Investment Banking, Advisory and other business relationships with a significant percentage of the companies covered by our Research Group. Our research professionals provide important inputs into the Group's Investment Banking and other business selection processes. Recipients of this report should assume that our Group is seeking or may seek or will seek Investment Banking, advisory, project finance or other businesses and may receive commission, brokerage, fees or other compensation from the company or companies that are the subject of this material/report. Our Company and Group companies and their officers, directors and employees, including the analysts and others involved in the preparation or issuance of this material and their dependants, may on the date of this report or from, time to time have "long" or "short" positions in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. Centrum or its affiliates do not own 1% or more in the equity of this company Our sales people, dealers, traders and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. We may have earlier issued or may issue in future reports on the companies covered herein with recommendations/ information inconsistent or different those made in this report. In reviewing this document, you should be aware that any or all of the foregoing, among other things, may give rise to or potential conflicts of interest. We and our Group may rely on information barriers, such as "Chinese Walls" to control the flow of information contained in one or more areas within us, or other areas, units, groups or affiliates of Centrum. Centrum or its affiliates do not make a market in the security of the company for which this report or any report was written. Further, Centrum or its affiliates did not make a market in the subject companys securities at the time that the research report was published. This report is for information purposes only and this document/material should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this document nor anything contained herein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. This document does not solicit any action based on the material contained herein. It is for the general information of the clients of Centrum. Though disseminated to clients simultaneously, not all clients may receive this report at the same time. Centrum will not treat recipients as clients by virtue of their receiving this report. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. Similarly, this document does not have regard to the specific investment objectives, financial situation/circumstances and the particular needs of any specific person who may receive this document. The securities discussed in this report may not be suitable for all investors. The securities described herein may not be eligible for sale in all jurisdictions or to all categories of investors. The countries in which the companies mentioned in this report are organized may have restrictions on investments, voting rights or dealings in securities by nationals of other countries. The appropriateness of a particular investment or strategy will depend on an investor's individual circumstances and objectives. Persons who may receive this document should consider and independently evaluate whether it is suitable for his/ her/their particular circumstances and, if necessary, seek professional/financial advice. Any such person shall be responsible for conducting his/her/their own investigation and analysis of the information contained or referred to in this document and of evaluating the merits and risks involved in the securities forming the subject matter of this document. The projections and forecasts described in this report were based upon a number of estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections and forecasts were based will not materialize or will vary significantly from actual results, and such variances will likely increase over time. All projections and forecasts described in this report have been prepared solely by the authors of this report independently of the Company. These projections and forecasts were not prepared with a view toward compliance with published guidelines or generally accented accounting principles. No independent accountants have expressed an opinion or any other form of assurance on these projections or forecasts. You should not regard the inclusion of the projections and forecasts described herein as a representation or warranty by or on behalf of the Company, Centrum, the authors of this report or any other person that these projections or forecasts or their underlying assumptions will be achieved. For these reasons, you should only consider the projections and forecasts described in this report after carefully evaluating all of the information in this report, including the assumptions underlying such projections and forecasts. The price and value of the investments referred to in this document/material and the income from them may go down as well as up, and investors may realize losses on any investments. Past performance is not a guide for future performance. Future returns are not guaranteed and a loss of original capital may occur. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Centrum does not provide tax advice to its clients, and all investors are strongly advised to consult regarding any potential investment. Centrum and its affiliates accept no liabilities for any loss or damage of any kind arising out of the use of this report. Foreign currencies denominated securities are subject to fluctuations in exchange rates that could have an adverse effect on the value or price of or income derived from the investment. In addition, investors in securities such as ADRs, the value of which are influenced by foreign currencies effectively assume currency risk. Certain transactions including those involving futures, options, and other derivatives as well as non-investment-grade securities give rise to substantial risk and are not suitable for all investors. Please ensure that you have read and understood the current risk disclosure documents before entering into any derivative transactions. This report/document has been prepared by Centrum, based upon information available to the public and sources, believed to be reliable. No representation or warranty, express or implied is made that it is accurate or complete. Centrum has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The opinions expressed in this document/material are subject to change without notice and have no obligation to tell you when opinions or information in this report change. This report or recommendations or information contained herein do/does not constitute or purport to constitute investment advice in publicly accessible media and should not be reproduced, transmitted or published by the recipient. The report is for the use and consumption of the recipient only. This publication may not be distributed to the public used by the public media without the express written consent of Centrum. This report or any portion hereof may not be printed, sold or distributed without the written consent of Centrum. This report has not been prepared by Centrum Securities LLC. However, Centrum Securities LLC has reviewed the report and, in so far as it includes current or historical information, it is believed to be reliable, although its accuracy and completeness cannot be guaranteed. The distribution of this document in other jurisdictions may be restricted by law, and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Neither Centrum nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information. This document does not constitute an offer or invitation to subscribe for or purchase or deal in any securities and neither this document nor anything contained herein shall form the basis of any contract or commitment whatsoever. This document is strictly confidential and is being furnished to you solely for your information, may not be distributed to the press or other media and may not be reproduced or redistributed to any other person. The distribution of this report in other jurisdictions may be restricted by law and persons into whose possession this report comes should inform themselves about, and observe any such restrictions. By accepting this report, you agree to be bound by the fore going limitations. No representation is made that this report is accurate or complete. The opinions and projections expressed herein are entirely those of the author and are given as part of the normal research activity of Centrum Broking and are given as of this date and are subject to change without notice. Any opinion estimate or projection herein constitutes a view as of the date of this report and there can be no assurance that future results or events will be consistent with any such opinions, estimate or projection.

17

RelianceCapital Capital Reliance

This document has not been prepared by or in conjunction with or on behalf of or at the instigation of, or by arrangement with the company or any of its directors or any other person. Information in this document must not be relied upon as having been authorized or approved by the company or its directors or any other person. Any opinions and projections contained herein are entirely those of the authors. None of the company or its directors or any other person accepts any liability whatsoever for any loss arising from any use of this document or its contents or otherwise arising in connection therewith. Centrum and its affiliates have not managed or co-managed a public offering for the subject company in the preceding twelve months. Centrum and affiliates have not received compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for service in respect of public offerings, corporate finance, debt restructuring, investment banking or other advisory services in a merger/acquisition or some other sort of specific transaction. As per the declarations given by them, Mr. Bhavesh Kanani, research analyst and and/or any of his family members do not serve as an officer, director or any way connected to the company/companies mentioned in this report. Further, as declared by him, he has not received any compensation from the above companies in the preceding twelve months. Our entire research professionals are our employees and are paid a salary. They do not have any other material conflict of interest of the research analyst or member of which the research analyst knows of has reason to know at the time of publication of the research report or at the time of the public appearance. While we would endeavour to update the information herein on a reasonable basis, Centrum, its associated companies, their directors and employees are under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent Centrum from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or Centrum policies, in circumstances where Centrum is acting in an advisory capacity to this company, or any certain other circumstances Key to Centrum Investment Rankings: Stock to Sector Sector to Market Outperform Outperform Neutral Underperform Outperform Neutral Neutral Underperform Outperform Underperform Neutral Underperform Accumulate: Add on decline; Reduce: Sell on rise Stock to Sector This is the relative rating of the stock to the sector and reflects its relative attractiveness vis--vis other coverage stocks in the sector. Sector to Market This is the relative rating of the sector vis--vis the other sectors in the coverage space. This is derived based on the conviction of the analyst on a sector and macro view outlined in market strategy. Stock to Market The final rating on the stock is obtained as a combination of the stock to sector and sector to market view as outlined in the table above. Stock to Market Buy Buy Accumulate Neutral Neutral Neutral Reduce Sell Sell

18

RelianceCapital Capital Reliance

Member (NSE, BSE, MCX-SX), Depository Participant (CDSL) and SEBI registered Portfolio Manager Registration Nos. CAPITAL MARKET SEBI REGN. NO.: BSE: INB011454239, NSE: INB231454233 DERIVATIVES SEBI REGN. NO.: NSE: INF231454233 (TRADING & SELF CLEARING MEMBER) CDSL DP ID: 12200. SEBI REGISTRATION NO.: IN-DP-CDSL-661-2012 PMS REGISTRATION NO.: INP000004383 MCX SX (Currency Derivative segment) REGN. NO.: INE261454236 Website: www.centrum.co.in Investor Grievance Email ID: [email protected] Compliance Officer Details: Mr. Praveen Malik; Tel: (022) 4215 9703; Email ID: [email protected]

Centrum Broking Limited


Registered Office Address Bombay Mutual Building , 2nd Floor, Dr. D. N. Road, Fort, Mumbai - 400 001 Correspondence Address Centrum House 6th Floor, CST Road, Near Vidya Nagari Marg, Kalina, Santacruz (E), Mumbai 400 098. Tel: (022) 4215 9000

19

RelianceCapital Capital Reliance

You might also like